Related Experiment Videos

Inhibition of growth of mouse ehrlich ascites by normal tissue extracts

Chemotherapy
|January 1, 1978
PubMed

Insights

Researchers discovered a substance in mouse muscle and liver extracts that inhibits Ehrlich ascites tumor growth. This finding suggests potential therapeutic applications for cancer treatment.

Area of Science:

  • Biochemistry
  • Oncology
  • Pharmacology

Background:

  • Ehrlich ascites is a common model for studying tumor growth.
  • Identifying novel anti-cancer agents is crucial for therapeutic development.

Purpose of the Study:

  • To investigate the presence and properties of tumor-inhibitory components in mouse tissues.
  • To evaluate the anti-tumor efficacy of these components in vivo.

Main Methods:

  • Aqueous extraction of mouse skeletal muscle and liver.
  • In vitro assessment of growth inhibition against Ehrlich ascites.
  • In vivo studies involving intraperitoneal injection into tumor-inoculated mice.

Main Results:

  • A dialyzable component from mouse skeletal muscle and liver inhibited Ehrlich ascites growth in vitro.
  • This inhibitory component was not found in spleen, kidney, lung, skin, serum, or small intestine.
  • The muscle and liver components exhibited differential stability to heat and culture conditions but were stable during storage.
  • Intraperitoneal administration of these components significantly reduced tumor incidence in mice.

Conclusions:

  • Mouse skeletal muscle and liver contain potent, dialyzable anti-tumorigenic components.
  • These components demonstrate efficacy in both in vitro and in vivo models of Ehrlich ascites.
  • Further research into the characterization and therapeutic potential of these compounds is warranted.

Related Concept Videos